<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27883291</PMID>
        <DateCompleted>
            <Year>2017</Year>
            <Month>08</Month>
            <Day>30</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>01</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1744-8042</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <Issue>18</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Pharmacogenomics</Title>
                <ISOAbbreviation>Pharmacogenomics</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2097-2114</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Second-line treatment of high-grade osteosarcoma (HGOS) patients is based on different approaches and chemotherapy protocols, which are not yet standardized. Although several drugs have been used in HGOS second-line protocols, none of them has provided fully satisfactory results and the role of rescue chemotherapy is not well defined yet. This article focuses on the drugs that have most frequently been used for second-line treatment of HGOS, highlighting the present knowledge on their mechanisms of action and resistance and on gene polymorphisms with possible impact on treatment sensitivity or toxicity. In the near future, validation of the so far identified candidate genetic biomarkers may constitute the basis for tailoring treatment by taking the patients' genetic background into account.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hattinger</LastName>
                    <ForeName>Claudia M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pharmacogenomics &amp; Pharmacogenetics Research Unit of the Laboratory of Experimental Oncology, Orthopaedic Rizzoli Institute, Via di Barbiano 1/10, I-40136 Bologna, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vella</LastName>
                    <ForeName>Serena</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pharmacogenomics &amp; Pharmacogenetics Research Unit of the Laboratory of Experimental Oncology, Orthopaedic Rizzoli Institute, Via di Barbiano 1/10, I-40136 Bologna, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tavanti</LastName>
                    <ForeName>Elisa</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pharmacogenomics &amp; Pharmacogenetics Research Unit of the Laboratory of Experimental Oncology, Orthopaedic Rizzoli Institute, Via di Barbiano 1/10, I-40136 Bologna, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fanelli</LastName>
                    <ForeName>Maril√π</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pharmacogenomics &amp; Pharmacogenetics Research Unit of the Laboratory of Experimental Oncology, Orthopaedic Rizzoli Institute, Via di Barbiano 1/10, I-40136 Bologna, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Picci</LastName>
                    <ForeName>Piero</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Experimental Oncology, Orthopaedic Rizzoli Institute, Via di Barbiano 1/10, I-40136 Bologna, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Serra</LastName>
                    <ForeName>Massimo</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pharmacogenomics &amp; Pharmacogenetics Research Unit of the Laboratory of Experimental Oncology, Orthopaedic Rizzoli Institute, Via di Barbiano 1/10, I-40136 Bologna, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Pharmacogenomics</MedlineTA>
            <NlmUniqueID>100897350</NlmUniqueID>
            <ISSNLinking>1462-2416</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001859" MajorTopicYN="N">Bone Neoplasms</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012516" MajorTopicYN="N">Osteosarcoma</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010597" MajorTopicYN="N">Pharmacogenetics</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CYP450</Keyword>
            <Keyword MajorTopicYN="N">adverse drug reactions</Keyword>
            <Keyword MajorTopicYN="N">chemotherapy</Keyword>
            <Keyword MajorTopicYN="N">drug resistance</Keyword>
            <Keyword MajorTopicYN="N">drug transporter genes</Keyword>
            <Keyword MajorTopicYN="N">osteosarcoma</Keyword>
            <Keyword MajorTopicYN="N">pharmacogenomics</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>8</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27883291</ArticleId>
            <ArticleId IdType="doi">10.2217/pgs-2016-0116</ArticleId>
            <ArticleId IdType="pmc">PMC5558522</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Treat Rev. 2015 Dec;41(10):935-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26585358</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 2011 Apr;47(6):895-902</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21216138</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Blood Cancer. 2006 Nov;47(6):790-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16435380</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Drug Metab Toxicol. 2014 Oct;10 (10 ):1337-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25162314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>HPB (Oxford). 2007;9(2):150-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18333132</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mutat Res. 2008 Feb 1;638(1-2):90-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17953974</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 1997 Oct;33(11):1725-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9470825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr Hematol Oncol. 2006 Jul;28(7):418-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16825986</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1992 Sep 15;70(6 Suppl):1799-809</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1355404</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2000 May 1;86(3):399-407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10760829</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Drugs. 1997 Oct;8(9):811-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9402307</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2003 Apr 15;21(8):1574-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12697883</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Adv Hematol Oncol. 2005 Apr;3(4):297-9; discussion 300-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16167002</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncotarget. 2016 Sep 20;7(38):61970-61987</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27566557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Oncol. 1992 Apr;19(2 Suppl 5):3-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1384141</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Oncol. 1995 Aug;22(4 Suppl 11):3-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7481842</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2009 Jun 1;27(16):2604-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19349540</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2002 Jan 15;20(2):426-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11786570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Cell Dev Biol. 2000;16:89-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11031231</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Blood Cancer. 2014 Aug;61(8):1376-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24692087</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2016 Aug;17 (8):1070-1080</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27324280</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1997 Sep 27;350(9082):911-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9314869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Res Rev. 2012 Nov;32(6):1220-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21374643</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2001 Jan;7(1):32-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11205914</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2014 Sep 9;111(6):1150-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25010864</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2015 Sep 20;33(27):3029-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26304877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2013 Nov 1;19(21):5972-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23989978</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Treat Rep. 1984 Apr;68(4):661-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6370429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2005 Mar 11;280(10 ):9586-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15613478</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2015 Dec 03;6:8940</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26632267</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Emerg Drugs. 2010 Dec;15(4):615-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20690888</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1998 Mar;16(3):945-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9508177</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Blood Cancer. 2005 Apr;44(4):338-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15503297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hum Genet. 2009 Oct;54(10):564-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19696793</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1042-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16343180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 1997 Feb;33(2):232-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9135494</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Emerg Drugs. 2015 Sep;20(3):495-514</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26021401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Chemother Pharmacol. 2014 Dec;74(6):1191-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25257509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19934256</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2015 Aug 1;21(15):3436-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25829401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1997 Jan;15(1):76-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8996127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2007 Apr 15;109(8):1646-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17334983</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Drug Metab Toxicol. 2015;11(9):1449-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26095223</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Ther. 1991;51(2):257-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1784631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):245-257</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27758143</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Fundam Clin Pharmacol. 2015 Feb;29(1):62-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25283245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Ther Oncol. 1996 May;1(3):186-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9414403</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 2011 Nov;47(16):2431-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21703851</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2006 May;17 Suppl 5:v7-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16807468</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacokinet. 2014 Aug;53(8):741-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24968986</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1998 Jul;16(7):2452-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9667263</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Resist Updat. 2002 Feb;5(1):19-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12127861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2003 Feb 15;21(4):710-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12586810</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Chem Inf Model. 2013 Apr 22;53(4):997-1006</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23521602</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 1991 Jan 1;51(1):227-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1703034</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2008 Nov 15;14(22):7167-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19010832</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Ther. 2014 Jan;141(1):92-116</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24076267</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2006 Jan 15;106(2):403-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16353204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Treat Rev. 2003 Oct;29(5):371-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12972356</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Surg Oncol. 2008 Jul;34(7):734-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17764884</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Med. 1997;48:353-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9046968</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2016 Oct;17 (10 ):1396-1408</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27569442</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tumour Biol. 2015 Jul;36(7):5451-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25677905</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Pediatr Oncol. 2000 Nov;35(5):468-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11070479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Pharmacol. 1994 Jul 19;48(2):301-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7519854</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2009 Jul 1;115(13):2980-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19452540</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Blood Cancer. 2012 Nov;59(5):854-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22302783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1985 Aug;82(16):5328-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2410919</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 2007 Mar;43(4):752-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17267204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr Hematol Oncol. 2001 Aug-Sep;23(6):340-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11563767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Chemother. 2004 Dec;16(6):582-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15700851</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Blood Cancer. 2014 May;61(5):833-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24249672</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013 Dec 04;8(12):e82363</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24349265</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Pharmacother. 2015;16(18):2727-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26512909</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Surg. 2014 Apr;38(4):813-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24170155</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Med Chem. 2011;18(3):439-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21143116</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1996 Aug 15;78(4):741-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8756366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2001 Aug 1;19(15):3463-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11481351</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2008 Jul 15;113(2):419-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18484657</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr Hematol Oncol. 2012 Mar;34(2):e63-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22217487</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 1998 Feb;4(2):357-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9516923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2016 Sep;17 (9):1261-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27498913</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Chemother Pharmacol. 1999;44(5):355-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10501907</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Oncol. 1999 Dec;16(4):255-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10618688</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2003 Oct 20;22(47):7296-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14576839</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2015 Feb;26(2):407-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25421877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2002 Jan;2(1):48-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11902585</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Fundam Clin Pharmacol. 2015 Jun;29(3):219-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25817555</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Pharm Des. 1999 Aug;5(8):587-605</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10469893</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1999 Jun;17 (6):1815-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10561220</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Blood Cancer. 2014 Nov;61(11):2096-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24753077</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 2012 Oct;48(15):2409-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22633624</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med Sci. 2012 Sep;344(3):199-205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22222334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 2004 Sep;24(17):7612-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15314169</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung Cancer. 2003 May;40(2):157-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12711116</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1994 Feb 15;73(4):1297-301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8313334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Blood Cancer. 2015 Jul;62(7):1214-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25809532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Blood Cancer. 2014 May;61(5):840-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24254749</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Treat Res. 2009;152:339-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20213400</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2005 Jan 20;23(3):559-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15659502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2002 Apr 15;20(8):2150-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11956277</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Blood Cancer. 2006 Mar;46(3):345-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16206197</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>